# Protein Intake Dosage on the Prognosis of Neurocritical Patients

> **NCT07295301** · NA · NOT_YET_RECRUITING · sponsor: **Wenshan City People's Hospital** · enrollment: 216 (estimated)

## Conditions studied

- Neurocritical Conditions
- Traumatic Brain Injury
- Ischemic Stroke

## Interventions

- **DIETARY_SUPPLEMENT:** Low-Dose Enteral Protein Supplementation (Enteral Nutrition Formulas + Whey Protein Powder)
- **DIETARY_SUPPLEMENT:** Moderate-Dose Enteral Protein Supplementation (Enteral Nutrition Formulas + Whey Protein Powder)
- **DIETARY_SUPPLEMENT:** High-Dose Enteral Protein Supplementation (Enteral Nutrition Formulas + Whey Protein Powder)

## Key facts

- **NCT ID:** NCT07295301
- **Lead sponsor:** Wenshan City People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2028-06
- **Final completion:** 2028-10
- **Target enrollment:** 216 (ESTIMATED)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07295301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07295301, "Protein Intake Dosage on the Prognosis of Neurocritical Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07295301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*